Status:
COMPLETED
PET and MRI in Prognosis Prediction of NPC
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Nasopharyngeal carcinoma (NPC) differs from other head and neck malignancies terms of its epidemiology, pathology, and treatment outcome. Integrated PET/MRI is a new imaging modality, which can simult...
Detailed Description
1. Background: Nasopharyngeal carcinoma (NPC) has a higher local tumor control rate but a higher incidence of distant metastasis compared with squamous cell carcinomas of other regions of the head...
Eligibility Criteria
Inclusion
- Biopsy proven primary nasopharyngeal carcinoma
- Age \> or = 20
- Willing to receive therapy
- The ability to provide written informed consent and receive the scheduled scans
Exclusion
- Woman with pregnancy or during lactation
- A history of other malignancies or concomitant cancers in different anatomical locations
- Not suitable to receive the PET scan such as serum glucose levels of \> 200 mg/dL or space phobia
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT03429868
Start Date
August 1 2015
End Date
July 31 2020
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Linkou Chang Gung Memorial Hospital
Taoyuan District, Taiwan